Marotte, Lucine <br/><br/>
Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes.  [electronic resource] 

 -  Journal for immunotherapy of cancer  01 2020 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2051-1426 
<br/><br/><label>Standard No.: </label>10.1136/jitc-2019-000311  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line, Tumor<br/>Female<br/>Gene Editing<br/>Humans<br/>Immunotherapy, Adoptive--methods<br/>Melanoma--immunology<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Programmed Cell Death 1 Receptor--deficiency<br/>Random Allocation<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Transfection<br/>Xenograft Model Antitumor Assays